MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species

Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan.
Cardiovascular Research (Impact Factor: 5.81). 07/2008; 78(3):554-62. DOI: 10.1093/cvr/cvn035
Source: PubMed

ABSTRACT Monocyte chemoattractant protein-1 (MCP-1: CCL2) has been demonstrated to be involved in the pathophysiology of ischaemic heart disease; however, the precise role of MCP-1 in ischaemia/reperfusion (I/R) injury is controversial. Here, we investigated the role of cardiac MCP-1 expression on left ventricular (LV) dysfunction after global I/R in Langendorff-perfused hearts isolated from transgenic mice expressing the mouse JE-MCP-1 gene under the control of the alpha-cardiac myosin heavy chain promoter (MHC/MCP-1 mice).
In vitro experiments showed that MCP-1 prevented the apoptosis of murine neonatal cardiomyocytes after hypoxia/reoxygenation. I/R significantly increased the mRNA expression of MCP-1 in the Langendorff-perfused hearts of wild-type mice. Cardiac MCP-1 overexpression in the MHC/MCP-1 mice improved LV dysfunction after I/R without affecting coronary flow; in particular, it ameliorated LV diastolic pressure after reperfusion. This improvement was independent of both sarcolemmal and mitochondrial K(ATP) channels. Cardiac MCP-1 overexpression prevented superoxide generation in the I/R hearts, and these hearts showed decreased expression of the NADPH oxidase family proteins Nox1, gp91phox, and Nox3 compared with the hearts of wild-type mice. Further, superoxide dismutase activity in the hearts of MHC/MCP-1 mice was significantly increased compared with that in the hearts of wild-type mice.
These findings suggest that cardiac MCP-1 prevented LV dysfunction after global I/R through a reactive oxygen species-dependent but K(ATP) channel-independent pathway; this provides new insight into the beneficial role of MCP-1 in the pathophysiology of ischaemic heart diseases.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Monocyte chemoattractant protein 1 (MCP1) is an important chemoattractant for microglia. Rodent MCP1 carries a heavily glycosylated C-terminus, which has been predicted to increase local MCP1 concentration, promote MCP1 dimerization/oligomerization, and facilitate receptor engagement. Previous studies have shown that MCP1 mutant lacking the glycosylated C-terminus cannot dimerize/oligomerize, but has higher chemotactic potency than the wild-type (full-length) MCP1, suggesting that rodent MCP1 may function as a monomer. Although many groups support this hypothesis, there is no direct evidence on whether rodent MCP1 dimer is functional. In this paper, using forced recombinant dimeric MCP1 proteins we show that the mouse MCP1 dimer is unable to activate Rac1, promote protrusion of lamellipodia, or induce microglial migration, although it can bind to CCR2 and mediate its internalization. These results support the idea that signaling events mediated by MCP1 require the presence of the monomeric form of this chemokine.
    The International Journal of Biochemistry & Cell Biology 08/2014; 55. DOI:10.1016/j.biocel.2014.08.002 · 4.24 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The Chagas' disease parasite Trypanosoma cruzi elicits potent inflammatory response in acutely infected hearts that keeps parasitism in check and triggers cardiac abnormalities. A most-studied mechanism underlying innate immunity in T cruzi infection is Toll-like receptor (TLR) activation by lipids and other parasite molecules. However, yet-to-be identified pathways should exist. Here, we show that T cruzi strongly upregulates monocyte chemoattractant protein-1 (MCP-1)/CCL2 and fractalkine (FKN)/CX3CL1 in cellular and mouse models of heart infection. Mechanistically, upregulation of MCP-1 and FKN stems from the interaction of parasite-derived neurotrophic factor (PDNF)/trans-sialidase with neurotrophic receptors TrkA and TrkC, as assessed by pharmacological inhibition, neutralizing antibodies and gene silencing studies. A single dose of intravenous PDNF into naïve mice results in a dose-dependent increase in MCP-1 and FKN in the heart and liver, with pulse-like kinetics that peaks 3-h post-injection. Intravenous PDNF also augments MCP-1 and FKN in TLR signaling-deficient MyD88 knockout mice, underscoring the MyD88-independent action of PDNF. Although single PDNF injections do not increase MCP-1 and FKN receptors, multiple PDNF injections at short intervals up receptor transcripts in the heart and liver, suggesting that sustained PDNF triggers cell recruitment at infection sites. Thus, given that MCP-1 and FKN are chemokines essential to the recruitment of immune cells to combat inflammation triggers and to enhance tissue repair, our findings uncover a new mechanism in innate immunity of T cruzi infection mediated by Trk signaling, akin to an endogenous inflammatory and fibrotic pathway resulting from cardiomyocyte-TrkA recognition by matricellular connective tissue growth factor (CTGF/CCN2).
    Infection and Immunity 06/2014; 82(9). DOI:10.1128/IAI.02098-14 · 4.16 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: -Myocardial reperfusion following ischemia (I/R), while an effective approach in rescuing the ischemic myocardium, can itself trigger a number of adverse effects including aberrant remodeling of the myocardium and its extracellular matrix (ECM). Tissue inhibitor of metalloproteinases (TIMPs) protect the ECM against excess degradation by matrix metalloproteinases (MMPs). TIMP4 levels are reduced in myocardial infarction; however its causal role in progression of post-I/R injury has not been explored.
    Circulation Heart Failure 05/2014; 7(4). DOI:10.1161/CIRCHEARTFAILURE.114.001113 · 5.95 Impact Factor